Stay updated on Ponatinib for Medullary Thyroid Cancer Clinical Trial

Sign up to get notified when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Ponatinib for Medullary Thyroid Cancer Clinical Trial page

  1. Check
    5 days ago
    Change Detected
    Summary
    Footer updated to show Revision: v3.3.3 and remove references to HHS Vulnerability Disclosure and Revision: v3.3.2.
    Difference
    0.1%
    Check dated 2025-12-23T14:24:41.000Z thumbnail image
  2. Check
    12 days ago
    No Change Detected
  3. Check
    19 days ago
    No Change Detected
  4. Check
    33 days ago
    Change Detected
    Summary
    Revision: v3.3.2 was added and revision v3.2.0 was removed.
    Difference
    0.1%
    Check dated 2025-11-24T17:48:03.000Z thumbnail image
  5. Check
    40 days ago
    Change Detected
    Summary
    The funding-status notice about lapse in government funding has been removed from the page. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T17:27:29.000Z thumbnail image
  6. Check
    55 days ago
    Change Detected
    Summary
    The study status is Withdrawn/Closed by sponsor with enrollment at 0, indicating no active recruitment.
    Difference
    0.5%
    Check dated 2025-11-03T12:11:38.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    - Updated page to v3.2.0 and removed the Medullary thyroid carcinoma resource. - Added a government funding/operating-status notice directing users to NIH and OPM sites for current operations.
    Difference
    5%
    Check dated 2025-10-05T16:44:31.000Z thumbnail image
  8. Check
    91 days ago
    Change Detected
    Summary
    Core content terminology updated from “Medullary thyroid gland carcinoma” to “Medullary thyroid carcinoma” and the release version updated to v3.1.0.
    Difference
    0.1%
    Check dated 2025-09-28T09:55:45.000Z thumbnail image

Stay in the know with updates to Ponatinib for Medullary Thyroid Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Ponatinib for Medullary Thyroid Cancer Clinical Trial page.